Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
folliculin | 0.537 | 0.885 | 0.79 |
|
disease | 0.900 | strong | 0.920 | 25 | 5 | 2002 | 2020 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
disease | 0.700 | strong | 0.970 | 236 | 15 | 1989 | 2019 | ||||||||
|
endothelial PAS domain protein 1 | 0.454 | 0.731 | 0.60 |
|
disease | 0.700 | None | 0.974 | 38 | 20 | 2001 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.700 | None | 1.000 | 35 | 3 | 1998 | 2020 | ||||||||
|
8-oxoguanine DNA glycosylase | 0.453 | 0.808 | 3.9E-12 |
|
disease | 0.620 | None | 1.000 | 3 | 1 | 2003 | 2011 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.600 | None | 1.000 | 14 | 0 | 2002 | 2019 | ||||||||
|
neurofibromin 2 | 0.468 | 0.885 | 1.00 |
|
disease | 0.510 | None | 1.000 | 2 | 0 | 2012 | 2015 | ||||||||
|
transcription factor binding to IGHM enhancer 3 | 0.542 | 0.654 | 0.98 |
|
disease | 0.500 | None | 0.983 | 120 | 0 | 1996 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.500 | None | 0.900 | 90 | 31 | 1991 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.983 | 58 | 8 | 2004 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.500 | None | 1.000 | 40 | 7 | 2006 | 2019 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.500 | None | 0.967 | 30 | 2 | 2011 | 2019 | ||||||||
|
TSC complex subunit 1 | 0.440 | 0.808 | 1.00 |
|
disease | 0.500 | None | 1.000 | 16 | 0 | 1995 | 2020 | ||||||||
|
melanocyte inducing transcription factor | 0.499 | 0.808 | 0.98 |
|
disease | 0.500 | None | 1.000 | 14 | 2 | 2003 | 2019 | ||||||||
|
elongin C | 0.656 | 0.500 | 0.74 |
|
disease | 0.460 | None | 1.000 | 8 | 2 | 2013 | 2019 | ||||||||
|
HNF1 homeobox B | 0.473 | 0.808 | 1.00 |
|
disease | 0.450 | None | 0.800 | 5 | 0 | 1999 | 2017 | ||||||||
|
solute carrier family 49 member 4 | 0.780 | 0.231 | 2.3E-09 |
|
disease | 0.430 | None | 1.000 | 3 | 0 | 2002 | 2017 | ||||||||
|
kelch like ECH associated protein 1 | 0.475 | 0.808 | 3.9E-04 |
|
disease | 0.420 | None | 1.000 | 3 | 0 | 2013 | 2019 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.420 | None | 1.000 | 2 | 0 | 1994 | 1999 | ||||||||
|
ring finger protein 139 | 0.670 | 0.423 | 0.54 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.400 | None | 0.953 | 43 | 9 | 1996 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.966 | 29 | 0 | 1989 | 2019 | ||||||||
|
polybromo 1 | 0.566 | 0.615 | 1.00 |
|
disease | 0.400 | None | 1.000 | 23 | 0 | 2011 | 2019 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 21 | 0 | 2004 | 2019 | ||||||||
|
TSC complex subunit 2 | 0.439 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 21 | 0 | 1994 | 2020 |